News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
525,813 Results
Type
Article (35745)
Company Profile (256)
Press Release (489812)
Section
Business (151067)
Career Advice (811)
Deals (26057)
Drug Delivery (63)
Drug Development (66928)
Employer Resources (68)
FDA (12596)
Job Trends (11096)
News (257036)
Policy (20341)
Tag
Academia (2048)
Alliances (43388)
Alzheimer's disease (1098)
Antibody-drug conjugate (ADC) (106)
Approvals (12567)
Artificial intelligence (183)
Bankruptcy (195)
Best Places to Work (9407)
Biotechnology (205)
Breast cancer (220)
Cancer (1623)
Cardiovascular disease (103)
Career advice (688)
CAR-T (114)
Cell therapy (316)
Clinical research (53200)
Collaboration (560)
Compensation (210)
COVID-19 (1739)
C-suite (118)
Data (1355)
Diabetes (133)
Diagnostics (5902)
Earnings (55286)
Events (81275)
Executive appointments (405)
FDA (13263)
Funding (481)
Gene therapy (186)
GLP-1 (450)
Government (2439)
Healthcare (14511)
Infectious disease (1822)
Inflammatory bowel disease (110)
IPO (12394)
Job creations (2101)
Job search strategy (591)
Layoffs (277)
Legal (3851)
Lung cancer (244)
Lymphoma (107)
Manufacturing (171)
Medical device (11936)
Medtech (11941)
Mergers & acquisitions (13958)
Metabolic disorders (361)
Neuroscience (1384)
NextGen: Class of 2025 (4813)
Non-profit (2927)
Northern California (1639)
Obesity (189)
Opinion (144)
Patents (120)
People (43051)
Phase I (18280)
Phase II (23708)
Phase III (16476)
Pipeline (565)
Postmarket research (1588)
Preclinical (7787)
Radiopharmaceuticals (252)
Rare diseases (233)
Real estate (4051)
Regulatory (15258)
Research institute (2072)
Resumes & cover letters (164)
Southern California (1460)
Startups (3121)
United States (14181)
Vaccines (413)
Weight loss (111)
Date
Today (23)
Last 7 days (395)
Last 30 days (1644)
Last 365 days (30365)
2025 (1422)
2024 (30710)
2023 (34929)
2022 (44744)
2021 (47427)
2020 (43738)
2019 (36229)
2018 (27037)
2017 (26697)
2016 (25142)
2015 (29202)
2014 (22004)
2013 (18152)
2012 (19443)
2011 (19765)
2010 (18348)
Location
Africa (440)
Arizona (134)
Asia (32800)
Australia (5782)
California (3729)
Canada (1235)
China (335)
Colorado (163)
Connecticut (184)
Europe (72063)
Florida (508)
Georgia (132)
Illinois (330)
Indiana (218)
Maryland (558)
Massachusetts (2861)
Michigan (174)
Minnesota (258)
New Jersey (967)
New York (1042)
North Carolina (635)
Northern California (1639)
Ohio (115)
Pennsylvania (778)
South America (658)
Southern California (1460)
Texas (553)
Utah (102)
Washington State (390)
525,813 Results for "cancer targeted technology".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Cancer Targeted Technology Receives Fast Track $2.4M Grant to Develop an Innovative PSMA-Targeted Small Molecule Drug Conjugate for Prostate Cancer
November 18, 2024
·
2 min read
Approvals
Astellas’ First-in-Class, Claudin-Targeted Therapy Wins FDA Nod for Certain Gastric Cancers
The regulator’s approval on Friday of Vyloy for gastric or gastroesophageal junction cancer makes it the first and only claudin 18.2–targeted therapy approved in the U.S. for these indications, according to Astellas.
October 21, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Calidi Biotherapeutics Presents Data Supporting RTNova Systemic Technology to Target Metastatic Lung Cancer
November 19, 2024
·
5 min read
Mergers & acquisitions
GSK Targets Rare Cancer With $1B+ Acquisition of IDRx
The first major deal of JPM 2025 will give GSK a promising small molecule drug for gastrointestinal stromal tumors.
January 13, 2025
·
2 min read
·
Tristan Manalac
Press Releases
CancerVax Targets Hard to Treat Pancreatic Cancer
December 11, 2024
·
5 min read
Press Releases
Next Generation CD40 Targeted Cancer Therapies
December 5, 2024
·
1 min read
Press Releases
GlyTherix to Partner with SHINE Technologies for Advancing Targeted Radiotherapy in Aggressive Cancers
September 18, 2024
·
4 min read
mRNA Cancer Vaccine As New Immunotherapy Approach To Target Cancer
mRNA cancer vaccines represent a groundbreaking immunotherapy approach designed to target cancer by leveraging the body’s own immune system to recognize and attack cancer cells.
May 23, 2024
·
4 min read
Bladder cancer
Protara, CG Oncology Tout Promising Bladder Cancer Outcomes
Protara is advancing a cell therapy that triggers both adaptive and innate antitumor immune responses, while CG Oncology’s approach makes use of an oncolytic immunotherapy that preferentially targets cancer cells and proliferates inside them, destroying them from the inside.
December 6, 2024
·
2 min read
·
Tristan Manalac
Brain cancer
Biopharma Takes on Deadly Brain Cancer After Decades of Failure
Emboldened by technological advances and a deeper knowledge of glioblastoma, Merck, Kazia Therapeutics, CorriXR Therapeutics and others are targeting the often-fatal brain tumor.
December 2, 2024
·
7 min read
·
Kate Goodwin
1 of 52,582
Next
